Subscribe to our Newsletters !!
A lion or eagle may come to mind when considering
In science, the interference of materials, reagent
Dr. Mohammed Enayat’s recent testimony on his ag
This year, the Hamburg based life sciences company
Unlike other medications, Vyvanse (Lisdexamfetamin
Since it’s an ingredient in so many foods, you h
In our cover story, we shine a spotlight on “ The Magazine
The U.S. Food and Drug Administration has endorsed a medication to treat newborn children and kids with HIV, with the medication having been created by drugmaker GlaxoSmithKline’s HIV drugs division ViiV Healthcare, the FDA and the GSK unit said.
The FDA said on Friday it was conceding Viiv the endorsement of Tivicay and Tivicay PD tablets “for suspension to treat HIV-1 disease in pediatric patients at any rate a month old and weighing in any event 3 kgs in blend with other antiretroviral medicines”.
The medication is at present under audit by the European Medicines Agency, ViiV, in which Pfizer and Shionogi have little stakes, said in a different articulation.
